Cml Biotech Limited - Company Profile

Q: Who are the current directors of Cml Biotech Limited?

The current directors of Cml Biotech Limited are Parapully Varkey Joshy, Jessy Poulose, Ashwin Paul, Paul Shalini, Ajayaghosh Ayyappan, Bhaskaranpillai Santoshkumar, Mr Paulose Jacob, Poulose Chaku.

It is a healthcare public limited company based in Aluva, Kerala, India, established in 1999.

1999 Aluva, Kerala, India Active

Last Updated: December 18, 2025

Access Report

About Cml Biotech Limited

Cml Biotech Limited, a active public limited company, was established on 07 April 1999 in Aluva, Kerala, India. Engaging in medical consumables & supplies within the manufacturing sector, it holds CIN: U51397KL1999PLC012944. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹43.28 Cr and a paid-up capital of ₹41.50 Cr.

Formerly known as Cml Biotech Private Limited. It upholds a compliant status. Employing 108 professional, Its leadership includes Parapully Varkey Joshy (Director), Jessy Poulose (Director), Ashwin Paul (Director). Past directors included Sreelakshmi Velamavukudy Mani, Sumi Joshy, Ajin Anto Madhathiparambil. It holds ₹77.67 Cr open charges and ₹30.40 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at C7 & C8, 2Nd Floor, Tower 2, Inkel Business Park, Angamaly South, Ernakulam, Aluva, Kerala, 683573.

Company Details

CIN/LLPIN
U51397KL1999PLC012944
Registration Number
012944
Incorporation Date
07 April 1999
Authorized Capital
₹43.28 Cr
Paid-Up Capital
₹41.50 Cr
ROC Code
Roc Ernakulam
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 43.28 Cr as on 18-12-2025
Paid Up Capital ₹ 41.50 Cr as on 18-12-2025
Company Age 27 Year, 1 Month
Last Filing with ROC 31 Mar 2024
Open Charges ₹ 77.67 Cr as on 18-12-2025
Satisfied Charges ₹ 30.40 Cr as on 18-12-2025
Revenue Growth **** -19.08% (FY 2023)
Profit Growth **** -88.70% (FY 2023)
Ebitda **** -45.90% (FY 2023)
Net Worth 15.19% (FY 2023)
Total Assets **** 52.12% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Cml Biotech Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Cml Biotech Limited?

Current Directors

Name	Designation	Appointment Date	Status
Parapully Varkey Joshy	Director	10 Jul 2018	Current
Jessy Poulose	Director	07 Apr 1999	Current
Ashwin Paul	Director	22 May 2021	Current
Paul Shalini	Director	22 May 2021	Current
Ajayaghosh Ayyappan	Director	03 May 2024	Current
Bhaskaranpillai Santoshkumar	Director	01 Jun 2023	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Company Secretary	-	Past
Pramod Abcsdd	Alternate Director	18 Mar 2024	Past
Pramod Abcsdd	Alternate Director	18 Mar 2024	Past
Pramod Abcsdd	Additional Director	30 Nov 2021	Past
Pramod Abcsdd	Additional Director	30 Nov 2021	Past
Pramod Abcsdd	Director	23 Sep 2024	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Cml Biotech.

Cml Biotech Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 19.08% decrease. The company also saw a substantial fall in profitability, with a 88.7% decrease in profit. The company's net worth Soared by an impressive increase of 15.19%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

-19.08%

*******

Revenue from Operations

*******

-19.14%

*******

Total Assets

*******

52.12%

*******

Profit or Loss

*******

-88.70%

*******

Net Worth

*******

15.19%

*******

EBITDA

*******

-45.90%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Cml Biotech?

In 2023, Cml Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹776,692,000.00

Satisfied Charges

₹303,992,000.00

Charges Breakdown by Lending Institutions

Axis Bank Limited : 41.77 Cr
Sidbi : 20.90 Cr
Hdfc Bank Limited : 15.00 Cr
The South Indian Bank Limited : 0.01 Cr

Latest Charge Details

Date	Lender	Amount	Status
30 Nov 2023	Sidbi	₹3.16 Cr	Open
27 Nov 2023	Sidbi	₹2.00 Cr	Open
19 Apr 2023	Sidbi	₹1.00 Cr	Open
01 Mar 2023	Sidbi	₹4.85 Cr	Open
29 Sep 2022	Hdfc Bank Limited	₹15.00 Cr	Open

Explore comprehensive loan charge details -

How Many Employees Work at Cml Biotech?

Cml Biotech has a workforce of 108 employees as of Nov 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Cml Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cml Biotech's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Cml Biotech

Recent Activity within the Organization

Charges

A charge registered on 14 Jul 2020 via Charge ID 100352129 with Axis Bank Limited was fully satisfied on 18 Jul 2025. was recorded as a recent event.
18 Jul 2025
Charges

The activity A charge with Axis Bank Limited of Rs. 41.08 Cr registered on 27 Sep 2019 with Charge ID 100295689 was modified on 19 Jun 2025. was completed.
19 Jun 2025
Annual General Meeting

Cml Biotech Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
30 Sep 2024
Director Appointment

Progress on Ajayaghosh Ayyappan was appointed as a Director was appointed as a Director on 03 May 2024 & has been associated with this company since 2 years 10 days . was documented.
03 May 2024
Balance Sheet

The activity Cml Biotech Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ernakulam. was completed.
31 Mar 2024
Charges

A charge with Sidbi amounted to Rs. 3.16 Cr with Charge ID 100822121 was registered on 30 Nov 2023. was recorded as a recent event.
30 Nov 2023

Explore recent activity and updates - View Recent Activity